Sangui Biotech International, Inc. Share Price
Equities
SBH
US80105B1017
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.002 EUR | -20.00% | -.--% | -33.33% |
Sales 2021 | 65.58K 60.79K 5.48M | Sales 2022 | 69.19K 64.13K 5.78M | Capitalization | 3.09M 2.86M 258M |
---|---|---|---|---|---|
Net income 2021 | - 0 0 | Net income 2022 | - 0 0 | EV / Sales 2021 | 90.6 x |
Net Debt 2021 | 790K 732K 65.95M | Net Debt 2022 | 795K 736K 66.33M | EV / Sales 2022 | 56.1 x |
P/E ratio 2021 |
-25.6
x | P/E ratio 2022 |
-51.8
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 86.94% |
1 day | -20.00% | ||
3 months | -33.33% | ||
6 months | -77.78% | ||
Current year | -33.33% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Striepe
CEO | Chief Executive Officer | 62 | 07/05/07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Striepe
CEO | Chief Executive Officer | 62 | 07/05/07 |
Hubertus Schmelz
BRD | Director/Board Member | 68 | 18/08/18 |
1st Jan change | Capi. | |
---|---|---|
-33.33% | 452K | |
+25.69% | 47.9B | |
+47.30% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- SBH Stock